Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Revolution Medicines Inc (RVMD)

Revolution Medicines Inc (RVMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,764,061
  • Shares Outstanding, K 74,245
  • Annual Sales, $ 29,390 K
  • Annual Income, $ -187,090 K
  • 60-Month Beta 1.69
  • Price/Sales 61.64
  • Price/Cash Flow N/A
  • Price/Book 3.29
Trade RVMD with:

Options Overview Details

View History
  • Implied Volatility 99.71% ( +8.04%)
  • Historical Volatility 85.44%
  • IV Percentile 79%
  • IV Rank 40.12%
  • IV High 160.58% on 05/10/22
  • IV Low 58.92% on 09/15/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 77
  • Put/Call OI Ratio 1.39
  • Today's Open Interest 1,768
  • Open Int (30-Day) 1,118

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.87
  • Number of Estimates 6
  • High Estimate -0.81
  • Low Estimate -0.92
  • Prior Year -0.60
  • Growth Rate Est. (year over year) -45.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.09 +28.39%
on 08/02/22
25.57 -4.15%
on 08/08/22
+1.10 (+4.70%)
since 07/08/22
3-Month
14.08 +74.08%
on 05/12/22
25.57 -4.15%
on 08/08/22
+8.59 (+53.96%)
since 05/10/22
52-Week
14.08 +74.08%
on 05/12/22
34.16 -28.25%
on 11/05/21
-2.61 (-9.62%)
since 08/10/21

Most Recent Stories

More News
Revolution Medicines, Inc. (RVMD) Reports Q2 Loss, Tops Revenue Estimates

Revolution Medicines, Inc. (RVMD) delivered earnings and revenue surprises of 5.75% and 4.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

RVMD : 24.51 (+3.16%)
VVOS : 1.2000 (-0.83%)
Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress

First two RAS(ON) Inhibitor drug candidates advance into clinical development Successful equity financing supports development of portfolio of targeted...

RVMD : 24.51 (+3.16%)
Revolution Medicines to Report Financial Results for Second Quarter 2022 After Market Close on August 9, 2022

REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel...

RVMD : 24.51 (+3.16%)
Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Underwriters’ full exercise of option brings gross proceeds to $264.5 million...

RVMD : 24.51 (+3.16%)
Revolution Medicines Announces Pricing of Upsized $230.0 Million Public Offering of Common Stock

REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

RVMD : 24.51 (+3.16%)
Revolution Medicines Announces Commencement of Public Offering of Common Stock

REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

RVMD : 24.51 (+3.16%)
Revolution Medicines Appoints Lorence Kim, M.D., Accomplished Health Care Industry Leader, to Board of Directors

Board composition evolves as company’s development pipeline matures...

RVMD : 24.51 (+3.16%)
Revolution Medicines Advances First RAS(ON) Inhibitor into Clinic, Dosing First Patient in Phase 1/1b Trial of RMC-6236

First-in-class, oral, RAS(ON) Inhibitor being evaluated initially in patients with cancers driven by KRASG12 mutations Sushil Patel, Ph.D., industry...

RVMD : 24.51 (+3.16%)
Revolution Medicines, Inc. (RVMD) Surges 5.6%: Is This an Indication of Further Gains?

Revolution Medicines, Inc. (RVMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in...

RVMD : 24.51 (+3.16%)
ALPN : 8.80 (+3.65%)
Revolution Medicines to Participate in the 43rd Annual Goldman Sachs Global Healthcare Conference

REDWOOD CITY, Calif., June 09, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted...

RVMD : 24.51 (+3.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.

See More

Key Turning Points

3rd Resistance Point 26.09
2nd Resistance Point 25.42
1st Resistance Point 24.59
Last Price 24.51
1st Support Level 23.08
2nd Support Level 22.41
3rd Support Level 21.58

See More

52-Week High 34.16
Fibonacci 61.8% 26.49
Last Price 24.51
Fibonacci 50% 24.12
Fibonacci 38.2% 21.75
52-Week Low 14.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar